SBI to come up with roadmap for merger of subsidiaries
SBI Chief Mrs Arundhati Bhattacharya said that, the bank will come out with roadmap of merger of its associate banks in a month’s time. The merger of associate banks with result in further expansion in market share and hence will be positive for bank over medium to long term.
Sun Pharma-Ranbaxy: Court approves merger
Sun Pharma-Ranbaxy merger: Gujarat High Court approves merger; sentimentally positive. The Gujarat High Court has approved the proposed merger of Sun Pharma and Ranbaxy. However, a crucial clearance from competition commission of India (CCI) and competition commission in US remains pending.
ICICI Bank gains 2% on stock split plans
Shares of private banking leader ICICI Bank Ltd gain 2% to Rs1763 on NSE as the bank has fixed record date as December 05, 2014 for the purpose of ascertaining the eligible shareholders who would be entitled to receive 5 (Five) equity shares of nominal value of Rs2 each in lieu of 1 (One) equity share of nominal value of Rs10 each of the Bank. Today the stock gained another 2 per cent as the stock rallied to a fresh all-time high of Rs 1,770. The stock is now up 1.8 per cent at Rs 1,766, and around 142,000 shares have changed hands at the counter so far on the BSE.
Tata Steel’s Thai unit expects net profit for 2014-15
Tata Steel’s Thai unit expects net profit for 2014-15; Sentimentally positive. It expects to post a net profit for the FY2015, bouncing back from a H1FY2015 loss by boosting sales of high-margin products. During H1FY2015, it reported a net loss of USD2.14mn due to weak construction demand and the impact of imports of steel bar products from China. It expects sales of more than 1.1 million tonne in the current financial year (as against 1.3 million tonne in previous year).
Aurobindo Pharma to consider raising of funds via securities
Aurobindo Pharma to consider raising of funds through securities; positive. The Board of Aurobindo Pharma is likely to meet on November 25, 2014, inter alia, to consider raising of funds through issue of securities. Aurobindo Pharma has recently announced to bidding for Natrol in US for US$132.5 million plus certain liabilities and it also plans Rs1300 crore capex over next two years. The company currently has debts close to US$440mn. The additional equities will ease off pressure on balance sheet.
Get Free Share Market Tips, MCX Tips Free Trial, NCDEX Tips, Commodity Tips, Nifty Futures Tips with profitable calls and tips.
0 comments:
Post a Comment